| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner
14 companies
Behbahani Ali is a 10% Owner at SVRA with holdings across 14 companies. Recent SEC Form 4 filings include 7 buys and 1 sell.
Estimated insider holdings value: $474.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | MRKR Marker Therapeutics, Inc. | 10% Owner | Buy | 5,714,285 | $1.75 | $9,999,998.75 | +114.3% | +91.4% | -77.7% | |
| Apr 3, 2020 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Sell | 564 | $2.66 | $1,500.24 | - | - | - | |
| Feb 3, 2020 | BDTX Black Diamond Therapeutics, Inc. | Director | Buy | 800,000 | $19.00 | $15,200,000.00 | +30.2% | - | - | |
| Jan 24, 2020 | Director | Buy | 7,500,000 | $0.67 | $5,000,250.00 | +62.5% | - | - | ||
| Jul 22, 2019 | MIRM Mirum Pharmaceuticals, Inc. | 10% Owner | Buy | 450,000 | $15.00 | $6,750,000.00 | +12.0% | - | - | |
| May 9, 2019 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +51.3% | - | - | |
| Sep 7, 2018 | Director | Buy | 12,000,000 | $1.67 | $20,000,400.00 | New | - | - |